ACTU Earnings ACTUATE THERAPEUTICS, INC.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q1 2026 | 2026-03-31 | -0.24 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -1.06 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -0.88 | 2025-11-13 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.63 | 2025-08-14 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.32 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -3.26 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -4.48 | 2025-11-13 | 10-Q |
| Q2 2025 | 2024-06-30 | -9.59 | 2025-08-14 | 10-Q |
| Q1 2025 | 2024-03-31 | -5.40 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -17.24 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -12.13 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -7.81 | 2024-09-24 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.